Mazdutide versus placebo in Chinese adults with type 2 diabetes
Dalong Zhu, Jiajun Zhao, Hanqing Cai, Xuan Chu, Shuangling Xiu, Chengwei Song, Zhifeng Cheng, Hongyi Cao, Hongwei Jiang, Lili Zhang, Haifang Wang, Bimin Shi, Yanbing Li, Ming Liu, Bo Feng, Fengtai Xue, Huan Deng, Haoyu Li, Li Li, Yue Li, Qingyang Ma, Lei Qian, on behalf of the DREAMS-1 Investigators
Topics & Concepts
MedicinePlaceboWeight lossType 2 diabetesInternal medicineAdverse effectDiabetes mellitusBody mass indexRandomized controlled trialAgonistType 2 Diabetes MellitusClinical endpointObesityAppetiteTolerabilityGlycemicGlucagon-like peptide 1 receptorGlycated haemoglobinEndocrinologyClinical trialIntention-to-treat analysisHypoglycemiaRandomizationBody weightOpen labelDiabetes Treatment and ManagementBariatric Surgery and OutcomesPharmacology and Obesity Treatment